Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction
Kim A. Connelly(St. Michael's Hospital), Richard E. Gilbert(St. Michael's Hospital)
Cited by 70
Related Papers
High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy
|Cardiovascular Diabetology|2014|130
Inhibition of Protein Kinase C–β by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy
|Circulation Heart Failure|2009|116
Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation
|Cardiovascular Research|2018|91